Home / Americas / Peru / Life Sciences & Healthcare

Life Sciences & Healthcare

CMS is an international leader in the Life Sciences & Healthcare Sector, with over 480 specialized lawyers and 100 Lifesciences companies as clients, including the top 20 global pharmaceutical companies and nine out of top ten global medical device companies.

In CMS Grau, our lawyers have extensive experience, having advised local and international investors in the areas of pharmaceuticals, agriculture, biotechnology and medical services.

Our multidisciplinary team of lawyers joins efforts to provide our clients with advice in a wide range of legal aspects that cover their businesses, such as regulatory, product liability, competition, public procurement, intellectual property, corporate and commercial issues; as well as disputes and mergers and acquisitions.

In Peru our lawyers have been involved in the working groups that developed the Regulations to the Sanitary Registry administered by the General Bureau of Medicines, Consumables and Drugs; and the Law for Pharmaceutical Centers. 


Feed

25/04/2024
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? In Peru, the advertising regulations of medicines and medical devices are included in:Law on Pharmaceuticals, Medical...
27/03/2024
Cannabis law and legislation in Peru
Medical use In general, Peruvian laws and regulations prohibit the growing, import and com­mer­cial­isa­tion of cannabis. Those activities are exclusively reserved for the Peruvian State when there are medical...
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
01/06/2022
CMS Next
What’s next? In a world of ever-ac­cel­er­at­ing change, staying ahead of the curve and knowing what’s next for your business or sector is essential. At CMS, we see ourselves not only as your legal advisers but also as your business partners. We work together with you to not only resolve current issues but to anticipate future challenges and innovate to meet them. With our latest publication, CMS Next, our experts will regularly offer you insights into and fresh perspectives on a range of issues that businesses have to deal with – from ESG agendas to restructuring after the pandemic or facing the digital transformation. We will also share with you more about the work that we are doing for our clients, helping them innovate, grow and mitigate risk. To be able to provide you with the best support, we immerse ourselves in your world to understand your legal needs and challenges. However, it is equally important that you know who we are and how we can work with you. So, we invite you to meet our experts and catch a glimpse of what is happening inside CMS. Enjoy reading this publication, which we will update regularly with new content. CMS Executive Team
05/04/2022
Beyond a personal brand
Beyond a personal brand
26/11/2021
CMS On the Pulse episode #10:  Digital Health law, regulations and developments...
The Global Life Sciences & Healthcare Sector Group, along with the Lifesciences Asia-Pacific Network (LAN), are delighted to release the latest episode in its video/podcast series, On the Pulse. The series...
04/11/2021
Update: CMS Expert Guide to International Arbitration – Americas
We are pleased to announce that the fifth volume of the CMS Expert Guide to International Arbitration has been published, covering seven jurisdictions in the Americas: Argentina, Brazil, Columbia, Chile...
15/06/2021
New GDPR Code of Conduct approved for Cloud Infrastructure Service Providers
The European Data Protection Board (EDPB) and the French Data Protection Authority (CNIL) approved the CISPE Data Protection Code of Conduct of Cloud Infrastructure Service Providers in Europe (CISPE...
09/06/2021
Open secrets? Guarding value in the intangible economy
We are delighted to share with you the report commissioned by CMS and written by The Economist Intelligence Unit. It explores the extent to which firms identify intangible assets as trade secrets and...
07/06/2021
CMS On the Pulse episode #9: A focus on compulsory licensing for phar­ma­ceut­ic­al...
The Global Life Sciences & Healthcare Sector Group is delighted to release the latest episode in its video/podcast series, On the Pulse. The series brings together CMS lawyers and experts to discuss key...
01/06/2021
Some leaks can't be fixed
“Confidential information is like an ice cube... give it to the party who has no refrigerator or will not agree to keep it in one, and by the time of the trial you have just a pool of water.” This...
29/04/2021
Updated CMS Expert Guide to A legal roadmap for Cannabis
2021 is shaping up to be a year of significant developments for the cannabis industry around the globe. Some countries have reformed their regulations on medical cannabis. In January 2021, a set of Rules...